Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

EIZO, MODEL FC-2091

K-Number: K022109 · 2002-07-12

ApplicantEizo Nanao Corporation
Decision Date2002-07-12
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

EIZO, MODEL FC-2091 is the device name listed in this FDA 510(k) record. The listed applicant is Eizo Nanao Corporation. It received FDA 510(k) clearance on 2002-07-12 under 510(k) number K022109. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the EIZO, MODEL FC-2091?

EIZO, MODEL FC-2091 is a medical device that received FDA 510(k) clearance on 2002-07-12. The listed applicant is Eizo Nanao Corporation. The 510(k) number is K022109.

When did EIZO, MODEL FC-2091 receive FDA 510(k) clearance?

EIZO, MODEL FC-2091 received FDA 510(k) clearance on 2002-07-12, under 510(k) number K022109.

Who is the listed applicant for EIZO, MODEL FC-2091?

The FDA 510(k) record lists Eizo Nanao Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for EIZO, MODEL FC-2091?

The FDA product code for EIZO, MODEL FC-2091 is LLZ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Eizo Nanao Corporation as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K1303365MP MONOCHROME LCD MONITOR, RADIFORCE GX540K1300704MP COLOR LCD MONITOR, RADIFORCE RX440K1204518MP COLOR LCD MONITOR, REDIFORCE RX840K1135623MP COLOR LCD MONITOR, RADIFORCE RX340K1132403.7 MP COLOR LCD MONITOR, RADIFORCE MX270WK1204072MP MONOCHROME LCD MONITOR, RADIFORCE GX240

View all 34 devices →

Related Devices (Code: LLZ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K261874Syneris PACS v.1.0.1.0SynerisK262442HipStudio AnalysisReplasia BVK261855Elucid PlaqueIQElucid Bioimaging, Inc.K254214OOOPDSTaiwan Main Orthopaedic Biotechnology Co., Ltd.K261861SPINEsim v1.0Mdsim S.A.K2620603D-RD-SRadiopharmaceutical Imaging & Dosimetry, LLC

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑